Biological potential and mechanism of prodigiosin from Serratia marcescens Subsp.lawsoniana in human choriocarcinoma and prostate cancer cell lines

  • Authors: Li, Dan; Liu, Jun; Wang, Xin; Kong, Di; Du, Wei; Li, Hongbo; Hse, Chung-Yun; Shupe, Todd; Zhou, Dongpo; Zhao, Kai
  • Publication Year: 2018
  • Publication Series: Scientific Journal (JRNL)
  • Source: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms19113465

Abstract

Tripyrrole molecules have received renewed attention due to reports of numerous biological activities, including antifungal, antibacterial, antiprotozoal, antimalarial, immunosuppressive, and anticancer activities. In a screen of bacterial strains with known toxicities to termites, a red pigment-producing strain, HDZK-BYSB107, was isolated from Chamaecyparis lawsoniana, which grows in Oregon, USA. Strain HDZK-BYSB107 was identified as Serratia marcescens subsp. lawsoniana. The red pigment was identified as prodigiosin using ultraviolet absorption, LC-MS, and 1H-NMR spectroscopy. The bacterial prodigiosin had an inhibitory effect on both Gram-negative and Gram-positive bacteria. The main objective of this study was to explore the anticancer activities and mechanism of strain HDZK-BYSB107 prodigiosin by using human choriocarcinoma (JEG3) and prostate cancer cell lines (PC3) in vitro and JEG3 and PC3 tumor-bearing nude mice in vivo. In vitro anticancer activities showed that the bacterial prodigiosin induced apoptosis in JEG3 cells. In vivo anticancer activities indicated that the prodigiosin significantly inhibited the growth of JEG3 and PC3 cells, and the inhibitory activity was dose and time dependent. The anticancer efficacy of the bacterial prodigiosin on JEG3 and PC3 cells, JEG3 and PC3 tumor exhibited a correlation with the down regulation of the inhibitor of IAP family, including XIAP, cIAP-1 and cIAP-2, and the activation of caspase-9 and caspase-3 accompanied by proteolytic degradation of poly (ADP-ribose)-polymerase. The expressions of P53 and Bax/Bcl-2 in JEG3 and PC3 cells were significantly higher than in untreated groups. Our results indicated that the bacterial prodigiosin extracted from C. lawsoniana is a promising molecule due to its potential for therapeutic applications.

  • Citation: Li, Dan; Liu, Jun; Wang, Xin; Kong, Di; Du, Wei; Li, Hongbo; Hse, Chung-Yun; Shupe, Todd; Zhou, Dongpo; Zhao, Kai. 2018. Biological potential and mechanism of prodigiosin from Serratia marcescens Subsp.lawsoniana in human choriocarcinoma and prostate cancer cell lines. International Journal of Molecular Sciences. 19(11): 3465-3485. https://doi.org/10.3390/ijms19113465.
  • Keywords: Serratia marcescens subsp. lawsoniana, prodigiosin, secondary metabolites, human choriocarcinoma cell lines and human prostate cancer cell lines, anticancer activities and mechanism
  • Posted Date: August 15, 2019
  • Modified Date: August 21, 2019
  • Print Publications Are No Longer Available

    In an ongoing effort to be fiscally responsible, the Southern Research Station (SRS) will no longer produce and distribute hard copies of our publications. Many SRS publications are available at cost via the Government Printing Office (GPO). Electronic versions of publications may be downloaded, printed, and distributed.

    Publication Notes

    • This article was written and prepared by U.S. Government employees on official time, and is therefore in the public domain.
    • Our online publications are scanned and captured using Adobe Acrobat. During the capture process some typographical errors may occur. Please contact the SRS webmaster if you notice any errors which make this publication unusable.
    • To view this article, download the latest version of Adobe Acrobat Reader.